Literature DB >> 31097678

Genital and anal Chlamydia trachomatis bacterial load in concurrently infected women: a cross-sectional study.

J A M C Dirks1,2, Genevieve A F S van Liere3,4, Christian J P A Hoebe5, Petra Wolffs6, Nicole H T M Dukers-Muijrers4.   

Abstract

OBJECTIVES: Most international STI guidelines recommend Chlamydia trachomatis anorectal testing in women after self-reported sexual exposure or symptoms in women. However, it has been shown that the prevalence of anorectal C. trachomatis is as high (7%-17 %) in women who do not report anorectal intercourse (AI) as in women who do. This study assessed the correlation between the genital and anorectal C. trachomatis load in concurrently infected women for increased microbiological insight.
METHODS: A convenience sample of 105 women with a concurrent (genital and anorectal) C. trachomatis infection was included from the STI clinic in South Limburg, the Netherlands. Women provided self-collected vaginal and anorectal swabs. The C. trachomatis load was quantified with qPCR and the human cell load was assessed to ensure sample adequacy. Genital and anorectal C. trachomatis loads were divided into tertiles for comparison. The χ2 test and linear regression were used to compare genital and anorectal C. trachomatis loads and identify determinants associated with load.
RESULTS: The overall median C. trachomatis load was higher in genital (median 5.3 log10 C. trachomatis/ml) than anorectal samples (median 3.4, p ≤ 0.001), but both loads were within the same range. The genital and anal load categories were not related within one woman (p = 0.99), both in women with and without AI. The anorectal C. trachomatis load was in the same or higher load category than the genital load in 56% of women without AI, and 79% of women with AI.
CONCLUSIONS: Although no cut-off for clinical relevance is known, an anorectal C. trachomatis load in the same or higher load category than the genital C. trachomatis load is likely to be clinically relevant. Other measurements should also be taken into account, such as leucocytes or bacterial viability to distinguish infection from contamination or exposure. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  bacterial load; chlamydia trachomatis; female genital disease; proctitis; urethritis

Mesh:

Year:  2019        PMID: 31097678     DOI: 10.1136/sextrans-2018-053678

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  4 in total

1.  Chlamydia trachomatis Infection Impairs MHC-I Intracellular Trafficking and Antigen Cross-Presentation by Dendritic Cells.

Authors:  Diego Del Balzo; Anahí Capmany; Ignacio Cebrian; María Teresa Damiani
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

2.  Comparative Analysis of the Incidence of Selected Sexually Transmitted Bacterial Infections in Poland in 2010-2015: A Retrospective Cohort Study.

Authors:  Magda Orzechowska; Mateusz Cybulski; Elzbieta Krajewska-Kulak; Agnieszka Gniadek; Wiaczeslaw Niczyporuk
Journal:  J Clin Med       Date:  2022-02-14       Impact factor: 4.241

3.  Metagenomic Shotgun Sequencing of Endocervical, Vaginal, and Rectal Samples among Fijian Women with and without Chlamydia trachomatis Reveals Disparate Microbial Populations and Function across Anatomic Sites: a Pilot Study.

Authors:  Sankhya Bommana; Timothy D Read; Deborah Dean; Gracie Richards; Mike Kama; Reshma Kodimerla; Kenan Jijakli
Journal:  Microbiol Spectr       Date:  2022-05-17

4.  Analytical Evaluation of the Abbott RealTime CT/NG Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Rectal and Pharyngeal Swabs.

Authors:  Paul C Adamson; Mark W Pandori; Sarah B Doernberg; Lauren Komarow; Zoe Sund; Thuy Tien T Tran; David Jensen; Ephraim L Tsalik; Carolyn D Deal; Henry F Chambers; Vance G Fowler; Scott R Evans; Robin Patel; Jeffrey D Klausner
Journal:  J Mol Diagn       Date:  2020-04-02       Impact factor: 5.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.